Patrick J. Mcenany - Aug 13, 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Stock symbol
CPRX
Transactions as of
Aug 13, 2021
Transactions value $
-$72,065
Form type
4
Date filed
8/17/2021, 04:53 PM
Next filing
Aug 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $312K +100K +2.08% $3.12* 4.91M Aug 13, 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$193K -31.2K -0.64% $6.17 4.88M Aug 13, 2021 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale -$192K -31.5K -0.65% $6.07 4.85M Aug 13, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -100K -2.82% $0.00 3.45M Aug 13, 2021 Common Stock 100K $3.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options and tax withholding requirements.
F2 Options vested in three annual tranches beginning on August 28, 2015.